Maryland's Special Populations Network. A model for cancer disparities research, education, and training.

Abstract:

:The unequal burden of cancer in minority and underserved communities nationally and in Maryland is a compelling crisis. The Maryland Special Populations Cancer Research Network (MSPN) developed an infrastructure covering Maryland's 23 jurisdictions and Baltimore City through formal partnerships between the University of Maryland School of Medicine, University of Maryland Statewide Health Network, University of Maryland Eastern Shore, and community partners in Baltimore City, rural Eastern Shore, rural Western Maryland, rural Southern Maryland, and Piscataway Conoy Tribe and statewide American Indians. Guided by the community-based participatory framework, the MSPN undertook a comprehensive assessment (of needs, strengths, and resources available) that laid the foundation for programmatic efforts in community-initiated cancer awareness and education, research, and training. The MSPN infrastructure was used to implement successful and innovative community-based cancer education interventions and technological solutions; conduct education and promotion of clinical trials, cancer health disparities research, and minority faculty cancer research career development; and leverage additional resources for sustainability. MSPN engaged in informed advocacy among decision- and policymakers at state and national levels, and its community-based clinical trials program was recognized by the U.S. Department of Health and Human Services as a Best Practice Award. The solutions to reduce and eliminate cancer health disparities are complex and require comprehensive and focused multidisciplinary cancer health disparities research, training, and education strategies implemented through robust community-academic partnerships. Cancer 2006. (c) American Cancer Society.

journal_name

Cancer

journal_title

Cancer

authors

Baquet CR,Mack KM,Mishra SI,Bramble J,Deshields M,Datcher D,Savoy M,Brooks SE,Boykin-Brown S,Hummel K

doi

10.1002/cncr.22158

subject

Has Abstract

pub_date

2006-10-15 00:00:00

pages

2061-70

issue

8 Suppl

eissn

0008-543X

issn

1097-0142

journal_volume

107

pub_type

杂志文章

相关文献

CANCER文献大全
  • Preradiation chemotherapy in advanced medulloblastoma. A Pediatric Oncology Group pilot study.

    abstract:BACKGROUND:Children diagnosed with medulloblastoma whose tumor involves the brain stem or has spread through the cerebrospinal fluid pathways to other areas of the brain or spinal cord have a poor prognosis despite therapy with surgery, craniospinal irradiation (CSI), and chemotherapy. Preradiation chemotherapy may imp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931101)72:9<2755::aid-cncr2820

    authors: Mosijczuk AD,Nigro MA,Thomas PR,Burger PC,Krischer JP,Morantz RA,Kurdunowicz B,Mulne AF,Towbin RB,Freeman AI

    更新日期:1993-11-01 00:00:00

  • Experimental studies on the radiation-modifying effect of cis-diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice.

    abstract::The effect of cis-diamminedichloroplatinum II (DDP) and ionizing radiation on human bladder transitional cell carcinoma (TCC) was evaluated in nude mouse-grown human tumors following administration of single-agent and combination treatment. Combination of DDP and radiation resulted in accelerated tumor regression and ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830801)52:3<452::aid-cncr28205

    authors: Kyriazis AP,Yagoda A,Kereiakes JG,Kyriazis AA,Whitmore WF Jr

    更新日期:1983-08-01 00:00:00

  • High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.

    abstract:BACKGROUND:The role of myeloablative chemotherapy in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors (MB/ST-PNET) is controversial, in particular in patients who develop recurrent disease after craniospinal radiotherapy. METHODS:In this retrospective analysis, the authors in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24341

    authors: Butturini AM,Jacob M,Aguajo J,Vander-Walde NA,Villablanca J,Jubran R,Erdreich-Epstein A,Marachelian A,Dhall G,Finlay JL

    更新日期:2009-07-01 00:00:00

  • High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission.

    abstract::The authors administered high-dose chemotherapy with cyclophosphamide, BCNU (carmustine) and VP-16 (etoposide) plus autologous bone marrow transplantation (ABMT) to 22 adult patients with relapsed acute leukemia in second or subsequent remission. The marrow was not treated ex vivo. The long-term, disease-free survival...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900815)66:4<619::aid-cncr28206

    authors: Spinolo JA,Dicke KA,Horwitz LJ,Jagannath S,McCredie K,Estey E,Kantarjian H,Zander AR,Keating M,Spitzer G

    更新日期:1990-08-15 00:00:00

  • Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung.

    abstract:BACKGROUND:The incidence of bronchioloalveolar carcinoma of the lung (BAC), a pathologically distinct type of nonsmall cell lung carcinoma (NSCLC), appears to be rising. In this study, the authors compared data on the clinical presentation and clinical courses of patients with Stage IIIB and IV BAC with data on other t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19991001)86:7<1165::aid-cn

    authors: Breathnach OS,Ishibe N,Williams J,Linnoila RI,Caporaso N,Johnson BE

    更新日期:1999-10-01 00:00:00

  • Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.

    abstract:BACKGROUND:Primary lymphomas of the uterus or cervix are so rare that treatment series of single institutions consist of very small numbers of patients, making standard treatment difficult to define. The outcome of patients treated with a combination of chemotherapy and radiation therapy was analyzed for all but patien...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950501)75:9<2392::aid-cncr2820

    authors: Stroh EL,Besa PC,Cox JD,Fuller LM,Cabanillas FF

    更新日期:1995-05-01 00:00:00

  • Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.

    abstract:BACKGROUND:Previous Phase II trials evaluating paclitaxel as a single agent have produced objective response rates of 38-40%. However, in these studies patients had recurrent disease and had received previous treatment with chemotherapy, radiation, surgery, or some combination of the same. To the authors' knowledge, th...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20001215)89:12<2587::aid-cncr11>

    authors: Grecula JC,Smith RE,Rhoades CA,Sharma P,Agrawal A,Zhang H,Allen J,Goldman FP,Young D,Schuller DE

    更新日期:2000-12-15 00:00:00

  • Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma.

    abstract:BACKGROUND:The objective of this study was to determine the potential economic implications resulting from using exemestane (EXE), a new steroidal, irreversible aromatase inactivator, compared with megestrol acetate (MA) in patients with advanced breast carcinoma. METHODS:The model used the clinical results from the m...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(20010201)91:3<484::aid-cncr1026>

    authors: Hillner BE,Radice D

    更新日期:2001-02-01 00:00:00

  • Mucin 1 antigens in the serum and bronchial lavage fluid of patients with lung cancer.

    abstract:BACKGROUND:Lung cancer (LC) is the most common fatal malignancy, but there are no useful tumor markers for diagnosis or monitoring. Mucin 1 has an established role as a marker in other malignancies, but has undergone limited assessment in LC. METHODS:Serum from 86 patients with LC and 24 with benign pulmonary disease ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931115)72:10<2936::aid-cncr282

    authors: Willsher PC,Xing PX,Clarke CP,Ho DW,McKenzie IF

    更新日期:1993-11-15 00:00:00

  • Quality-of-life outcomes for men with prostate carcinoma detected by screening.

    abstract:BACKGROUND:There is limited information on outcomes of prostate carcinoma treatments given to screened patient populations for whom cancer is usually detected at an earlier stage. METHODS:The authors conducted a cross-sectional evaluation of quality-of-life outcomes for men with prostate carcinoma detected in screenin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Smith DS,Carvalhal GF,Schneider K,Krygiel J,Yan Y,Catalona WJ

    更新日期:2000-03-15 00:00:00

  • A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.

    abstract::A prospective randomized trial by CALGB examined the relative value of four chemotherapy regimens in 537 patients with stage III B and IV Hodgkin's disease. A new combination BOPP, derived by substitution of BCNU for nitrogen mustard in the MOPP regimen, was compared to MOPP and to two 3-drug regimens, derived by remo...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(197901)43:1<31::aid-cncr28204301

    authors: Nissen NI,Pajak TF,Glidewell O,Pedersen-Bjergaard J,Stutzman L,Falkson G,Cuttner J,Blom J,Leone L,Sawitsky A,Coleman M,Haurani F,Spurr CL,Harley JB,Seligman B,Cornell C Jr,Henry P,Senn HJ,Brunner K,Martz G,Maurice

    更新日期:1979-01-01 00:00:00

  • Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics.

    abstract:BACKGROUND:Circulating prostate cells can be detected in the venous blood of patients with clinically localized prostate carcinoma by applying reverse transcriptase-polymerase chain reaction (RT-PCR) techniques using primers specific for the prostate specific antigen (PSA) gene. This study evaluates whether the detecti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970615)79:12<2402::aid-c

    authors: Ennis RD,Katz AE,de Vries GM,Heitjan DF,O'Toole KM,Rubin M,Buttyan R,Benson MC,Schiff PB

    更新日期:1997-06-15 00:00:00

  • Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose.

    abstract:BACKGROUND:In a cohort including 5112 prostate cancer (pCa) patients, the authors investigated associations among triglycerides (TG), total cholesterol (TC), and pCa while taking into account glucose. METHODS:A cohort (n = 200,660) based on 4 groups of men, according to age at cohort entry, with TG, TC, and glucose me...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25758

    authors: Van Hemelrijck M,Garmo H,Holmberg L,Walldius G,Jungner I,Hammar N,Lambe M

    更新日期:2011-05-15 00:00:00

  • Ganglioside composition of human neuroblastomas. Correlation with prognosis. A Pediatric Oncology Group Study.

    abstract::The ganglioside composition of neuroblastoma samples from 53 patients was determined. Tumor sites included the adrenals (15), and the thoracic (20), abdominal (15), and pelvic (3) areas. Age of the patients at the time of surgery ranged from 1 day to over 10 years and the Stage of the tumors from A to D. Differences i...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851201)56:11<2640::aid-cncr282

    authors: Schengrund CL,Repman MA,Shochat SJ

    更新日期:1985-12-01 00:00:00

  • Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma.

    abstract:BACKGROUND:Several of the large studies addressing prognosis and survival from hepatocellular carcinoma (HCC) have been from Europe and Asia, but only a few have emanated from North America. Survival statistics from other parts of the world may not be applicable to the North American population because of etiologic, de...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950815)76:4<579::aid-cncr28207

    authors: Nzeako UC,Goodman ZD,Ishak KG

    更新日期:1995-08-15 00:00:00

  • Marrow neutrophil reserve after adjuvant chemotherapy for carcinoma of the breast.

    abstract::The hematologic factors of 16 female patients with breast carcinoma who had received adjuvant chemotherapy with L-phenylalanine-based programs for two years were compared with those for 13 normal female volunteers of similar age. The findings include significant suppression of the mean hemoglobin level, of leukocyte c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820615)49:12<2455::aid-cncr282

    authors: Corder MP,Jochimsen PR

    更新日期:1982-06-15 00:00:00

  • Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.

    abstract:BACKGROUND:Colonoscopy is the most widely used colorectal cancer (CRC) screening test in the United States. Through the detection and removal of potentially precancerous polyps, it can prevent CRC. However, CRC screening remains low among adults who are recommended for screening. The New Hampshire Colorectal Cancer Scr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31864

    authors: Rice K,Sharma K,Li C,Butterly L,Gersten J,DeGroff A

    更新日期:2019-02-15 00:00:00

  • External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.

    abstract:BACKGROUND:The poor prognosis reported for patients with high-grade glial neoplasms indicates a need for the development of multimodality therapeutic approaches. The addition of chemotherapy has contributed variably to increased survival. The objective of the current study (Southwest Oncology Group [SWOG] 9016) was to ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.23585

    authors: Blumenthal DT,Rankin C,Eyre HJ,Livingston RB,Spence AM,Stelzer KJ,Rushing EJ,Berger MS,Rivkin SE,Cohn AL,Petersdorf SH

    更新日期:2008-08-01 00:00:00

  • Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.

    abstract::Biologicals and biological response modifiers (BRMs) represent a new class of agents for cancer therapy. Historically, there have been many attempts to stimulate the immune response with nonspecific immunomodulators in the form of bacterial extracts, viruses, and chemicals. Although these approaches have occasionally ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841201)54:2+<2795::aid-cncr282

    authors: Oldham RK,Thurman GB,Talmadge JE,Stevenson HC,Foon KA

    更新日期:1984-12-01 00:00:00

  • Interaction of molecular alterations with immune response in melanoma.

    abstract::Major advances have been made in melanoma treatment with the use of molecularly targeted therapies and immunotherapies, and numerous regimens are now approved by the US Food and Drug Administration for patients with stage IV disease. However, therapeutic resistance remains an issue to both classes of agents, and relia...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.30681

    authors: Szczepaniak Sloane RA,Gopalakrishnan V,Reddy SM,Zhang X,Reuben A,Wargo JA

    更新日期:2017-06-01 00:00:00

  • Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles.

    abstract:BACKGROUND:Nonionizing radiation, such as radiofrequency field and near infrared laser, induces thermal cytotoxicity in cancer cells treated with gold nanoparticles. Quantum dots are fluorescent semiconducting nanoparticles that were hypothesized to induce similar injury after radiofrequency field irradiation. METHODS...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25135

    authors: Glazer ES,Curley SA

    更新日期:2010-07-01 00:00:00

  • Alterations of peripheral blood B-lymphocyte populations in plasma cell disorders.

    abstract::Peripheral blood lymphocytes of patients with multiple myeloma, macroglobulinemia, and monoclonal gammopathy of uncertain significance were analyzed for B cells, and cells bearing kappa light chains and lambda light chains on their surfaces. Compared with controls, the number of B cells were decreased in all three gro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811115)48:10<2211::aid-cncr282

    authors: Dillman RO,Royston I,Meserve BL,Griffiths JC

    更新日期:1981-11-15 00:00:00

  • Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.

    abstract:BACKGROUND:The authors previously demonstrated that never-smokers with stage IIIB/IV nonsmall cell lung cancer (NSCLC) lived 50% longer than former/current smokers. This observation persisted after adjusting for age, performance status, and sex. In this study, the authors hypothesized that smoking-dependent differences...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27637

    authors: Paik PK,Johnson ML,D'Angelo SP,Sima CS,Ang D,Dogan S,Miller VA,Ladanyi M,Kris MG,Riely GJ

    更新日期:2012-12-01 00:00:00

  • Cytogenetic, histopathologic, and immunologic studies of multifocal renal cell carcinoma.

    abstract:BACKGROUND:Multifocal tumor areas occurred in 12-22% of patients with renal cell carcinoma. It is unknown whether these tumors have malignant potential and characterize a higher risk for metastases. The performance of nephron-sparing surgery in patients with low grade or low stage tumors is controversial. METHODS:Prim...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Junker K,Schlichter A,Junker U,Knöfel B,Kosmehl H,Schubert J,Claussen U

    更新日期:1997-03-01 00:00:00

  • Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy.

    abstract::This review presents our experience with the use of estrogen receptors (ER) and progesterone receptors (PgR) in the prediction of response to endocrine therapy in stage IV breast cancer. Presence of ER (> 3 fmol/mg cytosol protein) significantly predicted response to the antiestrogen tamoxifen and to hypophysectomy. E...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801215)46:12+<2838::aid-cncr28

    authors: Manni A,Arafah B,Pearson OH

    更新日期:1980-12-15 00:00:00

  • Physician interpretation of genomic test results and treatment selection.

    abstract:BACKGROUND:Genomic testing is increasingly performed in oncology, but concerns remain regarding the clinician's ability to interpret results. In the current study, the authors sought to determine the agreement between physicians and genomic annotators from the Precision Oncology Decision Support (PODS) team at The Univ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31112

    authors: Brusco LL,Wathoo C,Mills Shaw KR,Holla VR,Bailey AM,Johnson AM,Khotskaya YB,Litzenburger BC,Sanchez NS,Zeng J,Bernstam EV,Eng C,Kee BK,Amaria RN,Routbort MJ,Mills GB,Mendelsohn J,Meric-Bernstam F

    更新日期:2018-03-01 00:00:00

  • Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial.

    abstract:BACKGROUND:Screening colonoscopy (SC) for colorectal cancer (CRC) is underused by Latino individuals. The current randomized clinical trial examined the impact of 3 interventions: 1) patient navigation; 2) patient navigation plus standard Centers for Disease Control and Prevention print materials; and 3) patient naviga...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.32541

    authors: DuHamel KN,Schofield EA,Villagra C,Sriphanlop P,Itzkowitz SH,Cotter G,Cohen N,Erwin DO,Winkel G,Thompson HS,Zauber AG,Jandorf LH

    更新日期:2020-02-15 00:00:00

  • An unusual presentation of a large tumor coexisting with an unusually high nonspecific immune responsiveness. A case report.

    abstract::The authors present the case of a 40-year-old white man with an obstructing laryngeal mass. Despite considerable tumor size, results of repeated biopsies revealed widespread carcinoma in situ with chronic inflammation within the subcutaneous tissues, and only after extensive endoscopic "debulking" of the mass was a sm...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850801)56:3<490::aid-cncr28205

    authors: Eskinazi DP,Mihail R,Dichtel WG

    更新日期:1985-08-01 00:00:00

  • Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus.

    abstract::A leukocyte migration procedure was utilized to test cellular hypersensitivity of breast cancer patients' leukocytes to autologous and homologous breast cancer tissues and to murine milk containing murine mammary tumor virus (MuMTV). The in vitro responsiveness of the leukocytes and the antigenicity of breast cancer t...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197501)35:1<121::aid-cncr2820350

    authors: Black MM,Zachrau RE,Shore B,Moore DH,Leis HP Jr

    更新日期:1975-01-01 00:00:00

  • Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors.

    abstract::In a former series of 60 resected Stage II nonseminomatous germinal testis tumors the authors succeeded in demonstrating that adjuvant cisplatin, vinblastine, and bleomycin (PVB) was able to significantly improve survival (100% in 11 treated versus 28.5% in 7 historical controls, P less than 0.01) only in patients wit...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840315)53:6<1363::aid-cncr2820

    authors: Pizzocaro G,Zanoni F,Milani A,Piva L,Salvioni R,Pasi M,Pilotti S,Monfardini S

    更新日期:1984-03-15 00:00:00